↓ Skip to main content

Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs
1 blog
twitter
4 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.834729
Pubmed ID
Authors

Xiaoqiang Liang, Cheng Hu, Mian Han, Congying Liu, Xun Sun, Kui Yu, Honggang Gu, Jingzhe Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 19%
Student > Bachelor 2 13%
Unspecified 1 6%
Student > Doctoral Student 1 6%
Researcher 1 6%
Other 1 6%
Unknown 7 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 25%
Unspecified 2 13%
Chemistry 2 13%
Nursing and Health Professions 1 6%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2024.
All research outputs
#4,243,746
of 25,392,582 outputs
Outputs from Frontiers in oncology
#1,425
of 22,436 outputs
Outputs of similar age
#89,622
of 447,427 outputs
Outputs of similar age from Frontiers in oncology
#97
of 1,555 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,427 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 1,555 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.